Research prototype, not medical advice.

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults

Authors
Martens, Christopher R.; Denman, Blair A.; Mazzo, Melissa R.; Armstrong, Michael L.; Reisdorph, Nichole; McQueen, Matthew B.; Chonchol, Michel; Seals, Douglas R.
Journal
Nature Communications, 2018
Type
Study
DOI
doi:10.1038/s41467-018-03421-7
Status
Verified

Claims that rely on this source